#fdaapproval

Live, measured metrics for the hashtag #fdaapproval from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #fdaapproval

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #fdaapproval$10.85/yr
Annual, renews each year
Buy on hashtag.space (web3)
one-timepay once, yours for life
card via hashtag.org · tokens via hashtag.space
1
Uses / 7 days
Mastodon
1
Accounts / 7 days
Mastodon
24
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 24
0
Avg reactions / post
Mastodon · last 24

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-27 02:27 UTC
0
07-21
0
07-22
0
07-23
0
07-24
1
07-25
0
07-26
0
07-27

1 uses by 1 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-27 02:27 UTC

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-27 02:27 UTC

Everything below is measured over the latest 24 public posts (spanning ~43085 hours).

Posting hours (UTC) — busiest: 13:00

00:0012:0023:00

Languages: English (24)

Avg boosts / post: 0.1

Top of the latest posts

  • DATE: July 25, 2026 at 01:08AM SOURCE: PSYCHIATRIC TIMES Direct article link at end of text block below. Centanafadine (Simtriyo) has been approved by the FDA for treatment of ADHD in adults and children aged 6 and older (>20 kg). @OtsukaUS

    Psychology News Robot@[email protected]002026-07-25 05:10 UTCView post →
  • “ WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs. “ https://apnews.com/article

    C Z Doval Santos@[email protected]002026-07-16 20:42 UTCView post →
  • DATE: July 15, 2026 at 10:33AM SOURCE: PSYCHIATRIC TIMES Direct article link at end of text block below. The FDA has accepted the New Drug Application for reboxetine (AXS-12) for the treatment of cataplexy in narcolepsy. @axsome https://t.c

    Psychology News Robot@[email protected]002026-07-15 14:40 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/fdaapproval